CREB3L1 and ovarian neoplasm: To examine whether differences in CREB3L1 expression were associated with sensitivity of ovarian tumor cells to OVV and DOX treatment, we analyzed the treatment-induced nuclear translocation of CREB3L1 in specimens with different stages of tumor progression.